Ultragenyx Pharmaceutical, Inc. (RARE)
15.22
+0.47
(+3.19%)
USD |
NASDAQ |
Oct 02, 16:00
15.33
+0.11
(+0.72%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Max Drawdown (5Y) : 88.24% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 88.24% |
| August 31, 2026 | 88.24% |
| July 31, 2026 | 88.24% |
| June 30, 2026 | 88.24% |
| May 31, 2026 | 88.24% |
| April 30, 2026 | 88.24% |
| March 31, 2026 | 88.24% |
| February 28, 2026 | 88.24% |
| January 31, 2026 | 88.24% |
| December 31, 2025 | 88.24% |
| November 30, 2025 | 85.17% |
| October 31, 2025 | 85.17% |
| September 30, 2025 | 85.17% |
| August 31, 2025 | 85.17% |
| July 31, 2025 | 85.17% |
| June 30, 2025 | 82.49% |
| May 31, 2025 | 82.49% |
| April 30, 2025 | 82.49% |
| March 31, 2025 | 82.11% |
| February 28, 2025 | 82.11% |
| January 31, 2025 | 82.11% |
| December 31, 2024 | 82.11% |
| November 30, 2024 | 82.11% |
| October 31, 2024 | 82.11% |
| September 30, 2024 | 82.11% |
| Date | Value |
|---|---|
| August 31, 2024 | 82.11% |
| July 31, 2024 | 82.11% |
| June 30, 2024 | 82.11% |
| May 31, 2024 | 82.11% |
| April 30, 2024 | 82.11% |
| March 31, 2024 | 82.11% |
| February 29, 2024 | 82.11% |
| January 31, 2024 | 82.11% |
| December 31, 2023 | 82.11% |
| November 30, 2023 | 82.11% |
| October 31, 2023 | 82.11% |
| September 30, 2023 | 80.99% |
| August 31, 2023 | 80.99% |
| July 31, 2023 | 80.99% |
| June 30, 2023 | 80.99% |
| May 31, 2023 | 80.99% |
| April 30, 2023 | 80.99% |
| March 31, 2023 | 80.99% |
| February 28, 2023 | 80.99% |
| January 31, 2023 | 80.99% |
| December 31, 2022 | 80.99% |
| November 30, 2022 | 80.99% |
| October 31, 2022 | 79.11% |
| September 30, 2022 | 77.47% |
| August 31, 2022 | 74.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Biogen, Inc. | 72.66% |
| BioMarin Pharmaceutical, Inc. | 58.73% |
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.39 |
| Beta (5Y) | 0.3484 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.03% |
| Historical Sharpe Ratio (5Y) | -0.6275 |
| Historical Sortino (5Y) | -0.9616 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.09% |